This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1994 Feb;21(1):107-13.

Chemotherapy of metastatic endometrial cancer

H B Muss¹

Affiliations

PMID: 8310301

Review

Chemotherapy of metastatic endometrial cancer

H B Muss. Semin Oncol. 1994 Feb.

. 1994 Feb;21(1):107-13.

Author

H B Muss¹

Affiliation

¹ Department of Medicine, Wake Forest University, Bowman Gray School of Medicine, Winston-Salem, NC 27157-1065.

PMID: 8310301

No abstract available

PubMed Disclaimer

Similar articles

Current status of chemotherapy in gynecologic cancer.
Tropé C, Kristensen G. Tropé C, et al. Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-1-S15-22. Semin Oncol. 1997. PMID: 9346216 Review. No abstract available.
Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.
Pectasides D, Xiros N, Papaxoinis G, Pectasides E, Sykiotis C, Koumarianou A, Psyrri A, Gaglia A, Kassanos D, Gouveris P, Panayiotidis J, Fountzilas G, Economopoulos T. Pectasides D, et al. Gynecol Oncol. 2008 May;109(2):250-4. doi: 10.1016/j.ygyno.2008.01.028. Epub 2008 Mar 4. Gynecol Oncol. 2008. PMID: 18299146
Management of advanced-stage and recurrent endometrial cancer.
Ray M, Fleming G. Ray M, et al. Semin Oncol. 2009 Apr;36(2):145-54. doi: 10.1053/j.seminoncol.2008.12.006. Semin Oncol. 2009. PMID: 19332249 Review.
Is there any place for cytotoxic chemotherapy in endometrial cancer?
Steer C, Harper P. Steer C, et al. Best Pract Res Clin Obstet Gynaecol. 2001 Jun;15(3):447-67. doi: 10.1053/beog.2001.0188. Best Pract Res Clin Obstet Gynaecol. 2001. PMID: 11476565 Review.
[Latest information of therapeutic approach for endometrial cancer].
Katsumata N, Yamanaka Y, Kitagawa R. Katsumata N, et al. Gan To Kagaku Ryoho. 2002 Aug;29(8):1371-6. Gan To Kagaku Ryoho. 2002. PMID: 12214463 Review. Japanese.

See all similar articles

Cited by

Investigating the relative efficacies of combination chemotherapy of paclitaxel/carboplatin, with or without anthracycline, for endometrial carcinoma.
Fujiwara K, Egawa-Takata T, Ueda Y, Kimura T, Yoshino K, Fujita M, Miyatake T, Ohta Y, Kamiura S, Enomoto T, Kimura T. Fujiwara K, et al. Arch Gynecol Obstet. 2012 May;285(5):1447-53. doi: 10.1007/s00404-011-2154-9. Epub 2011 Nov 30. Arch Gynecol Obstet. 2012. PMID: 22127553 Free PMC article.
Pharmacologic inhibition of Akt in combination with chemotherapeutic agents effectively induces apoptosis in ovarian and endometrial cancer cell lines.
Fabi F, Adam P, Parent S, Tardif L, Cadrin M, Asselin E. Fabi F, et al. Mol Oncol. 2021 Aug;15(8):2106-2119. doi: 10.1002/1878-0261.12888. Epub 2021 Jan 4. Mol Oncol. 2021. PMID: 33338300 Free PMC article.
Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement.
Lee SW, Lee TS, Hong DG, No JH, Park DC, Bae JM, Seong SJ, Shin SJ, Ju W, Lee KH, Lee YK, Cho H, Lee C, Paek J, Kim HJ, Lee JW, Kim JW, Bae DS. Lee SW, et al. J Gynecol Oncol. 2017 Jan;28(1):e12. doi: 10.3802/jgo.2017.28.e12. Epub 2016 Oct 27. J Gynecol Oncol. 2017. PMID: 27894165 Free PMC article.
Establishment of three cisplatin-resistant endometrial cancer cell lines using two methods of cisplatin exposure.
Sagawa Y, Fujitoh A, Nishi H, Ito H, Yudate T, Isaka K. Sagawa Y, et al. Tumour Biol. 2011 Apr;32(2):399-408. doi: 10.1007/s13277-010-0133-6. Epub 2010 Nov 27. Tumour Biol. 2011. PMID: 21113744
Drug therapy for gynaecological cancer in older women.
van Rijswijk RE, Vermorken JB. van Rijswijk RE, et al. Drugs Aging. 2000 Jul;17(1):13-32. doi: 10.2165/00002512-200017010-00002. Drugs Aging. 2000. PMID: 10933513 Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions